Established in 2005, India-based SSPL is engaged in manufacturing, exporting and distributing APIs, with special focus on APIs associated with treatments for neglected diseases. The company - a subsidiary of the 45-year old Euresian-Group (now V-group) - has successfully marked its presence in over 60 countries. SSPL has set up its corporate office in India’s financial hub - Mumbai - and built a state-of-the-art manufacturing base in Vapi located in Gujarat, which has gained a reputation for being the API manufacturing hub of India.
SSPL has been leading innovation right from the inception of our manufacturing business which started with our own research platform in 1997. The company has developed a molecule “Pentosan Polysulfate Sodium” (PPS) from scratch when there was no information in public domain on the molecule and where there was no other player in the world other than the originator. The entire basket of products aims at global leadership at world’s best quality as per European and American standards at competitive prices.
The company has focused on bringing to market niche polysaccharides and import substitute. SSPL believes in a new business model, where new health solutions using old molecules can be a successful venture which benefits consumers as well as makes profits for the company.